Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.
Source | Last Updated |
---|---|
Alliance of Genome Resources | October 9, 2024 |
Disease ID | Disease Name | Alliance of Genome Resources ID ▲ | Species | Gene ID | Gene Symbol | FlyGlycoDB | Evidence Code Names | References |
---|---|---|---|---|---|---|---|---|
DOID:1793 | pancreatic cancer | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:10652 | Alzheimer's disease | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:1596 | depressive disorder | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:9976 | heroin dependence | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:1574 | alcohol use disorder | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:0050741 | alcohol dependence | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:10487 | Hirschsprung's disease | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:12894 | Sjogren's syndrome | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:2030 | anxiety disorder | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:0060161 | Kennedy's disease | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:14330 | Parkinson's disease | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:0080855 | Parkinsonism | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:2921 | glomerulonephritis | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:12689 | acoustic neuroma | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:9810 | polyarteritis nodosa | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:3049 | Churg-Strauss syndrome | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:1826 | epilepsy | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:12842 | Guillain-Barre syndrome | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:332 | amyotrophic lateral sclerosis | Xenbase:XB-GENE-865016 | Xenopus laevis (African clawed frog) | 779087 | gdnf.L |
|
||
DOID:3883 | Lynch syndrome | Xenbase:XB-GENE-865037 | Xenopus laevis (African clawed frog) | 399283 | acvr2a.L |
|
||
DOID:219 | colon cancer | Xenbase:XB-GENE-865037 | Xenopus laevis (African clawed frog) | 399283 | acvr2a.L |
|
||
DOID:1793 | pancreatic cancer | Xenbase:XB-GENE-865037 | Xenopus laevis (African clawed frog) | 399283 | acvr2a.L |
|
||
DOID:11695 | portal vein thrombosis | Xenbase:XB-GENE-865040 | Xenopus laevis (African clawed frog) | 398022 | igf1r.S |
|
||
DOID:11476 | osteoporosis | Xenbase:XB-GENE-865040 | Xenopus laevis (African clawed frog) | 398022 | igf1r.S |
|
||
DOID:12217 | Lewy body dementia | Xenbase:XB-GENE-865040 | Xenopus laevis (African clawed frog) | 398022 | igf1r.S |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024